{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:46:37Z","timestamp":1792788397496,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"China Postdoctoral Science Foundation","award":["2024M752391"],"award-info":[{"award-number":["2024M752391"]}],"id":[{"id":"https:\/\/ror.org\/0426zh255","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China","award":["82503645"],"award-info":[{"award-number":["82503645"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China","award":["82473240"],"award-info":[{"award-number":["82473240"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00901-5","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T10:36:59Z","timestamp":1784284619000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A senescence-associated gene signature predicts radiotherapy prognosis in non-small cell lung cancer and identifies CSF1 as a target to potentiate radioimmunotherapy"],"prefix":"10.1186","volume":"21","author":[{"given":"Shaochuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuze","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanhuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghe","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"901_CR1","doi-asserted-by":"crossref","unstructured":"Hendriks L, Remon J, Faivre-Finn C, et al. Non-small-cell lung cancer. Nat Rev Dis Primers. 2024;10(1):71.","DOI":"10.1038\/s41572-024-00551-9"},{"key":"901_CR2","doi-asserted-by":"crossref","unstructured":"Lynch C, Pitroda SP, Weichselbaum RR. Radiotherapy, immunity, and immune checkpoint inhibitors. Lancet Oncol. 2024;25(8):e352\u201362.","DOI":"10.1016\/S1470-2045(24)00075-5"},{"key":"901_CR3","doi-asserted-by":"crossref","unstructured":"Bugno J, Wang L, Yu X, et al. Targeting the dendritic cell-secreted immunoregulatory cytokine CCL22 alleviates radioresistance. Clin Cancer Res. 2024;30(19):4450\u201363.","DOI":"10.1158\/1078-0432.CCR-23-3616"},{"key":"901_CR4","doi-asserted-by":"crossref","unstructured":"Herrera FG, Ronet C, Ochoa de Olza M, et al. Low-dose radiotherapy reverses tumor immune desertification and resistance to immunotherapy. Cancer Discov. 2022;12(1):108\u201333.","DOI":"10.1158\/2159-8290.CD-21-0003"},{"key":"901_CR5","doi-asserted-by":"crossref","unstructured":"Meziani L, Mondini M, et al. Radio-induced lymphopenia in the era of anti-cancer immunotherapy. Int Rev Cell Mol Biol. 2023;378:1\u201330.","DOI":"10.1016\/bs.ircmb.2023.03.002"},{"key":"901_CR6","doi-asserted-by":"crossref","unstructured":"Piffk\u00f3 A, Yang K, Panda A, et al. Radiation-induced amphiregulin drives tumour metastasis. Nature. 2025;643(8072):810\u20139.","DOI":"10.1038\/s41586-025-08994-0"},{"key":"901_CR7","doi-asserted-by":"crossref","unstructured":"Ajoolabady A, Pratico D, Bahijri S, Tuomilehto J, Uversky VN, Ren J. Hallmarks of cellular senescence: biology, mechanisms, regulations. Exp Mol Med. 2025;57(7):1482\u201391.","DOI":"10.1038\/s12276-025-01480-7"},{"key":"901_CR8","doi-asserted-by":"crossref","unstructured":"Schmitt CA, Wang B, Demaria M. Senescence and cancer - role and therapeutic opportunities. Nat Rev Clin Oncol. 2022;19(10):619\u201336.","DOI":"10.1038\/s41571-022-00668-4"},{"key":"901_CR9","doi-asserted-by":"crossref","unstructured":"Lau L, Porciuncula A, Yu A, Iwakura Y, David G. Uncoupling the senescence-associated secretory phenotype from cell cycle exit via interleukin-1 inactivation unveils its protumorigenic role. Mol Cell Biol. 2019;39(12):e00586\u201318.","DOI":"10.1128\/MCB.00586-18"},{"key":"901_CR10","doi-asserted-by":"crossref","unstructured":"Ortiz-Montero P, Londo\u00f1o-Vallejo A, Vernot JP. Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence\/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line. Cell Commun Signal. 2017;15(1):17.","DOI":"10.1186\/s12964-017-0172-3"},{"key":"901_CR11","doi-asserted-by":"crossref","unstructured":"Dong Z, Luo Y, Yuan Z, Tian Y, Jin T, Xu F. Cellular senescence and SASP in tumor progression and therapeutic opportunities. Mol Cancer. 2024;23(1):181.","DOI":"10.1186\/s12943-024-02096-7"},{"key":"901_CR12","doi-asserted-by":"crossref","unstructured":"Assouline B, Kahn R, Hodali L, et al. Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma restrict CD8(+) T cell activation and limit responsiveness to immunotherapy in mice. Nat Commun. 2024;15(1):6162.","DOI":"10.1038\/s41467-024-50441-7"},{"key":"901_CR13","doi-asserted-by":"crossref","unstructured":"Schoetz U, Klein D, Hess J, et al. Early senescence and production of senescence-associated cytokines are major determinants of radioresistance in head-and-neck squamous cell carcinoma. Cell Death Dis. 2021;12(12):1162.","DOI":"10.1038\/s41419-021-04454-5"},{"key":"901_CR14","doi-asserted-by":"crossref","unstructured":"Ji J, Ding K, Cheng B, et al. Radiotherapy-induced astrocyte senescence promotes an immunosuppressive microenvironment in glioblastoma to facilitate tumor regrowth. Adv Sci (Weinh). 2024;11(15):e2304609.","DOI":"10.1002\/advs.202304609"},{"key":"901_CR15","unstructured":"Saltz J, Gupta R, Hou L, et al. Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images. Cell Rep. 2018;23(1):181\u2013e1937."},{"key":"901_CR16","doi-asserted-by":"crossref","unstructured":"Zhang Y, Hu J, Ji K, et al. CD39 inhibition and VISTA blockade may overcome radiotherapy resistance by targeting exhausted CD8\u2009+\u2009T cells and immunosuppressive myeloid cells. Cell Rep Med. 2023;4(8):101151.","DOI":"10.1016\/j.xcrm.2023.101151"},{"key":"901_CR17","doi-asserted-by":"crossref","unstructured":"Zhao M, Kiernan CH, Stairiker CJ, et al. Rapid in vitro generation of bona fide exhausted CD8\u2009+\u2009T cells is accompanied by Tcf7 promotor methylation. PLoS Pathog. 2020;16(6):e1008555.","DOI":"10.1371\/journal.ppat.1008555"},{"key":"901_CR18","doi-asserted-by":"crossref","unstructured":"Liu S, Ma S, Liu G, et al. CK2B induces CD8(+) T-cell exhaustion through HDAC8-mediated epigenetic reprogramming to limit the efficacy of anti-PD-1 therapy in non-small-cell lung cancer. Adv Sci (Weinh). 2025;12(16):e2411053.","DOI":"10.1002\/advs.202411053"},{"key":"901_CR19","doi-asserted-by":"crossref","unstructured":"Tachihara M, Tsujino K, Ishihara T, et al. Durvalumab plus concurrent radiotherapy for treatment of locally advanced non-small cell lung cancer: The DOLPHIN phase 2 nonrandomized controlled trial. JAMA Oncol. 2023;9(11):1505\u201313.","DOI":"10.1001\/jamaoncol.2023.3309"},{"key":"901_CR20","doi-asserted-by":"crossref","unstructured":"Ma L, Bai M, Wang Y, Zhai X, Yu J, Meng X. COX-2 inhibition synergizes with radioimmunotherapy by promoting TCF1+CD8+ T cell infiltration in NSCLC. Cancer Biol Med. 2025;22(12):1537-43.","DOI":"10.20892\/j.issn.2095-3941.2025.0205"},{"key":"901_CR21","doi-asserted-by":"crossref","unstructured":"Shao C, Zhang Y, Li H, et al. Radiotherapy-resistant prostate cancer cells escape immune checkpoint blockade through the senescence-related ataxia telangiectasia and Rad3-related protein. Cancer Commun (Lond). 2025;45(3):218\u201344.","DOI":"10.1002\/cac2.12636"},{"key":"901_CR22","doi-asserted-by":"crossref","unstructured":"Chockalingam S, Ghosh SS. Macrophage colony-stimulating factor and cancer: a review. Tumour Biol. 2014;35(11):10635\u201344.","DOI":"10.1007\/s13277-014-2627-0"},{"key":"901_CR23","doi-asserted-by":"crossref","unstructured":"Pyonteck SM, Akkari L, Schuhmacher AJ, et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med. 2013;19(10):1264\u201372.","DOI":"10.1038\/nm.3337"},{"key":"901_CR24","doi-asserted-by":"crossref","unstructured":"Xu J, Ding L, Mei J, et al. Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments. Signal Transduct Target Ther. 2025;10(1):268.","DOI":"10.1038\/s41392-025-02325-5"},{"key":"901_CR25","doi-asserted-by":"crossref","unstructured":"Li JR, Shaw V, Lin Y, et al. The prognostic effect of infiltrating immune cells is shaped by proximal M2 macrophages in lung adenocarcinoma. Mol Cancer. 2024;23(1):185.","DOI":"10.1186\/s12943-024-02080-1"},{"key":"901_CR26","doi-asserted-by":"crossref","unstructured":"Jones KI, Tiersma J, Yuzhalin AE, et al. Radiation combined with macrophage depletion promotes adaptive immunity and potentiates checkpoint blockade. EMBO Mol Med. 2018. 10(12).","DOI":"10.15252\/emmm.201809342"},{"key":"901_CR27","doi-asserted-by":"crossref","unstructured":"Parsons TM, Buelow KL, Hanna A, et al. Intratumoural haematopoietic stem and progenitor cell differentiation into M2 macrophages facilitates the regrowth of solid tumours after radiation therapy. Br J Cancer. 2022;126(6):927\u201336.","DOI":"10.1038\/s41416-021-01652-y"},{"key":"901_CR28","doi-asserted-by":"crossref","unstructured":"Seifert L, Werba G, Tiwari S, et al. Radiation therapy induces macrophages to suppress T-cell responses against pancreatic tumors in mice. Gastroenterology. 2016;150(7):1659\u2013e16725.","DOI":"10.1053\/j.gastro.2016.02.070"},{"key":"901_CR29","doi-asserted-by":"crossref","unstructured":"Kong Y, Zhao X, Xu M, et al. PD-1 inhibitor combined with radiotherapy and GM-CSF (PRaG) in patients with metastatic solid tumors: an open-label phase II study. Front Immunol. 2022;13:952066.","DOI":"10.3389\/fimmu.2022.952066"},{"key":"901_CR30","doi-asserted-by":"crossref","unstructured":"Xu Y, Kong Y, Ma Y, et al. Phase I\/II clinical study of PRaG regimen combined with intraperitoneal infusion of PD-1 inhibitor for advanced refractory solid tumors with cancerous ascites (PRaG4.0P study). Technol Cancer Res Treat. 2024;23:15330338241264169.","DOI":"10.1177\/15330338241264169"},{"key":"901_CR31","doi-asserted-by":"crossref","unstructured":"Baessler A, Vignali D. T cell exhaustion. Annu Rev Immunol. 2024;42(1):179\u2013206.","DOI":"10.1146\/annurev-immunol-090222-110914"},{"key":"901_CR32","doi-asserted-by":"crossref","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","DOI":"10.3322\/caac.21660"},{"key":"901_CR33","doi-asserted-by":"crossref","unstructured":"Zhang Y, Hu HH, Zhou SH, et al. PET-based radiomics visualizes tumor-infiltrating CD8 T cell exhaustion to optimize radiotherapy\/immunotherapy combination in mouse models of lung cancer. Biomark Res. 2023;11(1):10.","DOI":"10.1186\/s40364-023-00454-z"},{"key":"901_CR34","doi-asserted-by":"crossref","unstructured":"Kersten K, Hu KH, Combes AJ, et al. Spatiotemporal co-dependency between macrophages and exhausted CD8(+) T cells in cancer. Cancer Cell. 2022;40(6):624\u2013e6389.","DOI":"10.1016\/j.ccell.2022.05.004"},{"key":"901_CR35","doi-asserted-by":"crossref","unstructured":"Maeser D, Gruener RF, Huang RS. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021;22(6).","DOI":"10.1093\/bib\/bbab260"},{"key":"901_CR36","doi-asserted-by":"crossref","unstructured":"Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol. 2018;1711:243\u201359.","DOI":"10.1007\/978-1-4939-7493-1_12"},{"key":"901_CR37","doi-asserted-by":"crossref","unstructured":"Yang H, Lei Z, He J, et al. Single-cell RNA sequencing reveals recruitment of the M2-like CCL8high macrophages in Lewis lung carcinoma-bearing mice following hypofractionated radiotherapy. J Transl Med. 2024;22(1):306.","DOI":"10.1186\/s12967-024-05118-6"},{"issue":"9","key":"901_CR38","doi-asserted-by":"publisher","first-page":"100139","DOI":"10.1016\/j.patter.2020.100139","volume":"1","author":"D Osorio","year":"2020","unstructured":"Osorio D, Zhong Y, Li G, Huang JZ, Cai JJ. scTenifoldNet: a machine learning workflow for constructing and comparing transcriptome-wide gene regulatory networks from single-cell data. Patterns (N Y). 2020;1(9):100139.","journal-title":"Patterns (N Y)"},{"key":"901_CR39","doi-asserted-by":"crossref","unstructured":"Zhengkun C, Zeyuan C, Lu Z, et al. CAD hijacks STING to impair antitumor immunity and radiotherapy efficacy of colorectal cancer. Cell Death Dis. 2025;16(1):641.","DOI":"10.1038\/s41419-025-07964-8"},{"key":"901_CR40","doi-asserted-by":"crossref","unstructured":"Franco MS, Roque MC, de Barros A, de Oliveira Silva J, Cassali GD, Oliveira MC. Investigation of the antitumor activity and toxicity of long-circulating and fusogenic liposomes co-encapsulating paclitaxel and doxorubicin in a murine breast cancer animal model. Biomed Pharmacother. 2019;109:1728\u201339.","DOI":"10.1016\/j.biopha.2018.11.011"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00901-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00901-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00901-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:10:48Z","timestamp":1791987048000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00901-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["901"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00901-5","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"7 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were approved by the Animal Ethics and Welfare Committee of Tianjin Medical University Cancer Hospital (AE-2024072). All animal experiments were conducted in accordance with the Guide for the Care and Use of Laboratory Animals (National Academy Press, Washington, D.C., USA, 1996).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"203"}}